dimyristoylphosphatidylcholine and Obesity

dimyristoylphosphatidylcholine has been researched along with Obesity in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, Y; Du, K; Faizy, A; Lu, X; Luo, Z; Piomelli, D; Shan, J; Sun, L; Sun, Q; Yang, Q; Zhang, K	1

Other Studies

1 other study(ies) available for dimyristoylphosphatidylcholine and Obesity

Article	Year
Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity. Metabolism: clinical and experimental, 2022, Volume: 131 Topics: Angiotensin-Converting Enzyme 2; Animals; Chromatography, Liquid; COVID-19; Dimyristoylphosphatidylcholine; HEK293 Cells; Humans; Lung; Mice; Myristic Acid; Obesity; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface-Active Agents; Tandem Mass Spectrometry	2022

Article

Year

Reduced DMPC and PMPC in lung surfactant promote SARS-CoV-2 infection in obesity.

Metabolism: clinical and experimental, 2022, Volume: 131

Topics: Angiotensin-Converting Enzyme 2; Animals; Chromatography, Liquid; COVID-19; Dimyristoylphosphatidylcholine; HEK293 Cells; Humans; Lung; Mice; Myristic Acid; Obesity; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Surface-Active Agents; Tandem Mass Spectrometry

2022